• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌阴性、非甾体抗炎药阴性溃疡

Helicobacter pylori-negative nonsteroidal anti-inflammatory drug-negative ulcer.

作者信息

McColl Kenneth E L

机构信息

Medical Sciences, Gardiner Institute, Western Infirmary, Glasgow, Scotland, G11 6NT, UK.

出版信息

Gastroenterol Clin North Am. 2009 Jun;38(2):353-61. doi: 10.1016/j.gtc.2009.03.004.

DOI:10.1016/j.gtc.2009.03.004
PMID:19446263
Abstract

The most important clinical point for dyspeptic H pylori-negative NSAID-absent negative ulcers is to adequately ensure that these common risk factors are indeed absent. Once that is done, further investigations to include the rare causes of ulcer disease need to be performed and exclusion of underlying malignancy ensured. The possibility of the Zollinger Ellison syndrome should be considered, remembering that proton pump inhibitor therapy will mitigate its classical, clinical features.

摘要

对于消化不良、幽门螺杆菌阴性、未服用非甾体抗炎药的阴性溃疡患者,最重要的临床要点是充分确保这些常见风险因素确实不存在。一旦做到这一点,就需要进一步进行检查,包括排查溃疡病的罕见病因,并确保排除潜在恶性肿瘤。应考虑佐林格-埃利森综合征的可能性,要记住质子泵抑制剂治疗会减轻其典型的临床特征。

相似文献

1
Helicobacter pylori-negative nonsteroidal anti-inflammatory drug-negative ulcer.幽门螺杆菌阴性、非甾体抗炎药阴性溃疡
Gastroenterol Clin North Am. 2009 Jun;38(2):353-61. doi: 10.1016/j.gtc.2009.03.004.
2
[Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].[出血性消化性溃疡。幽门螺杆菌感染率及非甾体抗炎药/阿司匹林的使用情况]
Ugeskr Laeger. 2009 Jan 19;171(4):235-9.
3
Management of peptic ulcer disease not related to Helicobacter pylori or NSAIDs.非幽门螺杆菌或非甾体抗炎药相关性消化性溃疡病的管理
Am J Gastroenterol. 2002 Dec;97(12):2950-61. doi: 10.1111/j.1572-0241.2002.07068.x.
4
[Gastric ulcer and duodenal ulcer (excluding Zollinger-Ellison syndrome). Epidemiology, physiopathology, diagnosis, course, treatment].[胃溃疡和十二指肠溃疡(不包括佐林格-埃利森综合征)。流行病学、生理病理学、诊断、病程、治疗]
Rev Prat. 1999 Mar 1;49(5):547-54.
5
Helicobacter pylori-negative ulcer disease.幽门螺杆菌阴性溃疡病
J Gastroenterol. 2000;35 Suppl 12:47-50.
6
Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.香港家庭医生转诊的未经调查的消化不良患者中消化性溃疡疾病和幽门螺杆菌感染的患病率趋势。
Aliment Pharmacol Ther. 2005 Aug 1;22(3):243-9. doi: 10.1111/j.1365-2036.2005.02554.x.
7
Helicobacter pylori-negative peptic ulcer. What is its aetiopathogenesis and treatment?幽门螺杆菌阴性消化性溃疡。其病因发病机制及治疗方法是什么?
Rev Esp Enferm Dig. 2002 Nov;94(11):687-96.
8
[Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].[胃十二指肠病变与非甾体抗炎药。幽门螺杆菌在这种关系中起什么作用?]
Rev Esp Enferm Dig. 1998 Sep;90(9):655-64.
9
[Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].[非甾体抗炎药引起的胃部病变与幽门螺杆菌导致的炎症。存在增强作用还是减弱作用?]
Gastroenterol Hepatol. 1998 Jan;21 Suppl 1:20-4.
10
[What role today for Helicobacter pylori in peptic ulcer?].[如今幽门螺杆菌在消化性溃疡中扮演着什么角色?]
Gastroenterol Clin Biol. 2003 Mar;27(3 Pt 2):409-14.

引用本文的文献

1
Changing trends and characteristics of peptic ulcer disease: A multicenter study from 2010 to 2019 in Korea.消化性溃疡疾病的变化趋势和特征:韩国 2010 年至 2019 年的多中心研究。
World J Gastroenterol. 2023 Nov 28;29(44):5882-5893. doi: 10.3748/wjg.v29.i44.5882.
2
Upregulation of the TRPA1 Ion Channel in the Gastric Mucosa after Iodoacetamide-Induced Gastritis in Rats: A Potential New Therapeutic Target.碘乙酰胺诱导大鼠胃炎后胃黏膜中 TRPA1 离子通道的上调:一个潜在的新治疗靶点。
Int J Mol Sci. 2020 Aug 5;21(16):5591. doi: 10.3390/ijms21165591.
3
Analysis of the Relation between Periodontitis and Chronic Gastritis/Peptic Ulcer: A Cross-Sectional Study Using KoGES HEXA Data.
牙周炎与慢性胃炎/消化性溃疡关系的分析:基于 KoGES HEXA 数据的横断面研究。
Int J Environ Res Public Health. 2020 Jun 18;17(12):4387. doi: 10.3390/ijerph17124387.
4
The Physiology of the Gastric Parietal Cell.胃壁细胞的生理学。
Physiol Rev. 2020 Apr 1;100(2):573-602. doi: 10.1152/physrev.00016.2019. Epub 2019 Oct 31.
5
Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.基于 Zollinger-Ellison 综合征患者研究的对慢性高胃泌素血症和终身质子泵抑制剂治疗的影响/风险的深入了解。
Int J Mol Sci. 2019 Oct 16;20(20):5128. doi: 10.3390/ijms20205128.
6
Peptic Ulcer Disease: A Brief Review of Conventional Therapy and Herbal Treatment Options.消化性溃疡病:传统疗法与草药治疗选择的简要综述
J Clin Med. 2019 Feb 3;8(2):179. doi: 10.3390/jcm8020179.
7
Peptic Ulcer Disease and infection.消化性溃疡病与感染
Mo Med. 2018 May-Jun;115(3):219-224.
8
Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?钾竞争性酸阻滞剂(P-CABs):它们终于准备好在酸相关疾病中崭露头角了吗?
Clin Transl Gastroenterol. 2015 Oct 29;6(10):e119. doi: 10.1038/ctg.2015.39.
9
The stomach in health and disease.健康与疾病状态下的胃。
Gut. 2015 Oct;64(10):1650-68. doi: 10.1136/gutjnl-2014-307595. Epub 2015 Sep 4.
10
High Recurrence Rate of Idiopathic Peptic Ulcers in Long-Term Follow-up.特发性消化性溃疡长期随访中高复发率。
Gut Liver. 2013 Mar;7(2):175-81. doi: 10.5009/gnl.2013.7.2.175. Epub 2013 Mar 14.